Bonney Michael W's Form 4 filing
Alnylam Pharmaceuticals, Inc. (ALNY) · filed May 19, 2025
- Accession no.
- 0001735276-25-000072
- Filed
- May 19, 2025
- Trade date
- May 15, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 15 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.12M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bonney Michael WCIK 0001219016 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2025 | Common Stock | MOption exerciseAcquired | +11,250 | $131.21 | +$1,476,112.5 | 28,054 | Direct | |
| May 15, 2025 | Common Stock | SSaleDisposed | −549 | $267.14 | −$146,659.86 | 27,505 | Direct | |
| May 15, 2025 | Common Stock | SSaleDisposed | −729 | $268.56 | −$195,780.24 | 26,776 | Direct | |
| May 15, 2025 | Common Stock | SSaleDisposed | −245 | $269.79 | −$66,098.55 | 26,531 | Direct | |
| May 15, 2025 | Common Stock | SSaleDisposed | −431 | $271.68 | −$117,094.08 | 26,100 | Direct | |
| May 15, 2025 | Common Stock | SSaleDisposed | −660 | $273.16 | −$180,285.6 | 25,440 | Direct | |
| May 15, 2025 | Common Stock | SSaleDisposed | −882 | $273.75 | −$241,447.5 | 24,558 | Direct | |
| May 15, 2025 | Common Stock | SSaleDisposed | −301 | $275.63 | −$82,964.63 | 24,257 | Direct | |
| May 15, 2025 | Common Stock | SSaleDisposed | −1,263 | $277.16 | −$350,053.08 | 22,994 | Direct | |
| May 15, 2025 | Common Stock | SSaleDisposed | −1,239 | $278.01 | −$344,454.39 | 21,755 | Direct | |
| May 15, 2025 | Common Stock | SSaleDisposed | −432 | $280.03 | −$120,972.96 | 21,323 | Direct | |
| May 15, 2025 | Common Stock | SSaleDisposed | −372 | $281.10 | −$104,569.2 | 20,951 | Direct | |
| May 15, 2025 | Common Stock | SSaleDisposed | −802 | $282.03 | −$226,188.06 | 20,149 | Direct | |
| May 15, 2025 | Common Stock | SSaleDisposed | −1,728 | $282.81 | −$488,695.68 | 18,421 | Direct | |
| May 15, 2025 | Common Stock | SSaleDisposed | −1,617 | $283.83 | −$458,953.11 | 16,804 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2025 | Common Stock | MOption exerciseDisposed | −11,250 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.